Legis Daily

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

USA116th CongressHR-269| House 
| Updated: 1/10/2019
Anna G. Eshoo

Anna G. Eshoo

Democratic Representative

California

Cosponsors (7)
Brett Guthrie (Republican)Greg Walden (Republican)Debbie Dingell (Democratic)Diana DeGette (Democratic)Robert E. Latta (Republican)Susan W. Brooks (Republican)Frank Pallone (Democratic)

Homeland Security Committee, Veterans' Affairs Committee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs. Among other programs, the bill reauthorizes through FY2023 and revises the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC), the Hospital Preparedness Program, the CDC situational-awareness and biosurveillance program, the Emergency System for Advance Registration of Volunteer Health Professionals, the National Disaster Medical System, the Volunteer Medical Reserve Corps, the National Advisory Committee on Children and Disasters, the Strategic National Stockpile, and the Biomedical Advanced Research and Development Authority. In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams. The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 115-7328
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018

Bill from Previous Congress

HR 115-6378
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Jan 8, 2019
Introduced in House
Jan 8, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 8, 2019
Mr. Pallone moved to suspend the rules and pass the bill.
Jan 8, 2019
Considered under suspension of the rules. (consideration: CR H237-266)
Jan 8, 2019
DEBATE - The House proceeded with forty minutes of debate on H.R. 269.
Jan 8, 2019
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Jan 8, 2019
Considered as unfinished business. (consideration: CR H275-276)
Jan 9, 2019
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13). (text: CR H237-262)
View Vote
Jan 9, 2019
Motion to reconsider laid on the table Agreed to without objection.
Jan 9, 2019
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Jan 10, 2019
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.
Jun 24, 2019

Latest Companion Bill Action

S 116-1379
Signed by President.
  • Bill from Previous Congress

    HR 115-7328
    Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018


  • Bill from Previous Congress

    HR 115-6378
    Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018


  • January 8, 2019
    Introduced in House


  • January 8, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • January 8, 2019
    Mr. Pallone moved to suspend the rules and pass the bill.


  • January 8, 2019
    Considered under suspension of the rules. (consideration: CR H237-266)


  • January 8, 2019
    DEBATE - The House proceeded with forty minutes of debate on H.R. 269.


  • January 8, 2019
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • January 8, 2019
    Considered as unfinished business. (consideration: CR H275-276)


  • January 9, 2019
    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13). (text: CR H237-262)
    View Vote


  • January 9, 2019
    Motion to reconsider laid on the table Agreed to without objection.


  • January 9, 2019
    Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.


  • January 10, 2019
    Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.


  • June 24, 2019

    Latest Companion Bill Action

    S 116-1379
    Signed by President.

Health

Related Bills

  • S 116-2740: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
  • HR 116-345: SMASH Act
  • S 116-11: Strengthening the National Disaster Medical System Act of 2019
  • S 116-1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
  • HR 116-3443: To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
Administrative law and regulatory proceduresAdvanced technology and technological innovationsAdvisory bodiesAgingBlood and blood diseasesBorder security and unlawful immigrationCenters for Disease Control and Prevention (CDC)Chemical and biological weaponsChild healthChild safety and welfareComputer security and identity theftCongressional oversightConsumer affairsDisability and paralysisDisaster relief and insuranceDrug safety, medical device, and laboratory regulationEmergency communications systemsEmergency medical services and trauma careEmergency planning and evacuationEnvironmental healthFirst responders and emergency personnelFood and Drug Administration (FDA)General health and health care finance mattersGeneticsGovernment employee pay, benefits, personnel managementGovernment information and archivesGovernment liabilityHazardous wastes and toxic substancesHealth facilities and institutionsHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHomeland securityHospital careImmunology and vaccinationInfectious and parasitic diseasesInfrastructure developmentIntelligence activities, surveillance, classified informationIntergovernmental relationsJudicial review and appealsLicensing and registrationsMarketing and advertisingMedical researchMilitary medicineMinority healthMusculoskeletal and skin diseasesNatural disastersPerformance measurementPrescription drugsResearch and developmentSocial work, volunteer service, charitable organizationsState and local government operationsTechnology assessmentTerrorismUser charges and feesVeterinary medicine and animal diseasesWomen's healthWorld health

Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019

USA116th CongressHR-269| House 
| Updated: 1/10/2019
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs. Among other programs, the bill reauthorizes through FY2023 and revises the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC), the Hospital Preparedness Program, the CDC situational-awareness and biosurveillance program, the Emergency System for Advance Registration of Volunteer Health Professionals, the National Disaster Medical System, the Volunteer Medical Reserve Corps, the National Advisory Committee on Children and Disasters, the Strategic National Stockpile, and the Biomedical Advanced Research and Development Authority. In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams. The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 115-7328
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018

Bill from Previous Congress

HR 115-6378
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
Jan 8, 2019
Introduced in House
Jan 8, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 8, 2019
Mr. Pallone moved to suspend the rules and pass the bill.
Jan 8, 2019
Considered under suspension of the rules. (consideration: CR H237-266)
Jan 8, 2019
DEBATE - The House proceeded with forty minutes of debate on H.R. 269.
Jan 8, 2019
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Jan 8, 2019
Considered as unfinished business. (consideration: CR H275-276)
Jan 9, 2019
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13). (text: CR H237-262)
View Vote
Jan 9, 2019
Motion to reconsider laid on the table Agreed to without objection.
Jan 9, 2019
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Jan 10, 2019
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.
Jun 24, 2019

Latest Companion Bill Action

S 116-1379
Signed by President.
  • Bill from Previous Congress

    HR 115-7328
    Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018


  • Bill from Previous Congress

    HR 115-6378
    Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018


  • January 8, 2019
    Introduced in House


  • January 8, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • January 8, 2019
    Mr. Pallone moved to suspend the rules and pass the bill.


  • January 8, 2019
    Considered under suspension of the rules. (consideration: CR H237-266)


  • January 8, 2019
    DEBATE - The House proceeded with forty minutes of debate on H.R. 269.


  • January 8, 2019
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • January 8, 2019
    Considered as unfinished business. (consideration: CR H275-276)


  • January 9, 2019
    On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13). (text: CR H237-262)
    View Vote


  • January 9, 2019
    Motion to reconsider laid on the table Agreed to without objection.


  • January 9, 2019
    Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.


  • January 10, 2019
    Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.


  • June 24, 2019

    Latest Companion Bill Action

    S 116-1379
    Signed by President.
Anna G. Eshoo

Anna G. Eshoo

Democratic Representative

California

Cosponsors (7)
Brett Guthrie (Republican)Greg Walden (Republican)Debbie Dingell (Democratic)Diana DeGette (Democratic)Robert E. Latta (Republican)Susan W. Brooks (Republican)Frank Pallone (Democratic)

Homeland Security Committee, Veterans' Affairs Committee, Judiciary Committee, Energy and Commerce Committee

Health

Related Bills

  • S 116-2740: Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
  • HR 116-345: SMASH Act
  • S 116-11: Strengthening the National Disaster Medical System Act of 2019
  • S 116-1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
  • HR 116-3443: To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresAdvanced technology and technological innovationsAdvisory bodiesAgingBlood and blood diseasesBorder security and unlawful immigrationCenters for Disease Control and Prevention (CDC)Chemical and biological weaponsChild healthChild safety and welfareComputer security and identity theftCongressional oversightConsumer affairsDisability and paralysisDisaster relief and insuranceDrug safety, medical device, and laboratory regulationEmergency communications systemsEmergency medical services and trauma careEmergency planning and evacuationEnvironmental healthFirst responders and emergency personnelFood and Drug Administration (FDA)General health and health care finance mattersGeneticsGovernment employee pay, benefits, personnel managementGovernment information and archivesGovernment liabilityHazardous wastes and toxic substancesHealth facilities and institutionsHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive careHealth technology, devices, suppliesHomeland securityHospital careImmunology and vaccinationInfectious and parasitic diseasesInfrastructure developmentIntelligence activities, surveillance, classified informationIntergovernmental relationsJudicial review and appealsLicensing and registrationsMarketing and advertisingMedical researchMilitary medicineMinority healthMusculoskeletal and skin diseasesNatural disastersPerformance measurementPrescription drugsResearch and developmentSocial work, volunteer service, charitable organizationsState and local government operationsTechnology assessmentTerrorismUser charges and feesVeterinary medicine and animal diseasesWomen's healthWorld health